Funding supports development and commercialization of broad array of isotopes for medical, commercial and industrial...
Nusano Announces Series C Financing of Over $115M to Commercialize Radioisotopes
read more
News
Nusano and PharmaLogic Announce Strategic Supply Agreement to Enable Current and Emerging Radiopharmaceuticals
Nusano and PharmaLogic announced a supply agreement to provide a more efficient and reliable supply of critical radioisotopes. The agreement will increase access to on-demand radioisotope supplies provided by Nusano for use in pharmaceutical products produced in PharmaLogic’s network of facilities.
Nusano Names D. Scott Holbrook as Chairman of its Board
VALENCIA, Calif. – June 7, 2024 – Nusano, Inc., a physics company transforming the production of medical...
Nusano Expands Executive Management to Support Q1 2025 Radioisotope Commercialization
VALENCIA, Calif. – May 29, 2024 – Nusano, Inc., a physics company transforming the production of medical...
Nusano to Host Radiopharmaceuticals Educational Webinar
EVENT REPLAY NOW AVAILABLE Recorded June 28, 2024Nusano and LifeSci Advisors invite you to go back to school... Join...
Nusano to Present at Jefferies Radiopharma Innovation Summit
VALENCIA, Calif. – April 10, 2024 – Nusano, a physics company transforming the production of medical radioisotopes,...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates